Since our findings suggested that CDK7 inhibition may synergize with ABT-263 through downregulation of MCL1 expression, we next examined the function of MCL1 in the synergistic effect between THZ1 and ABT-263 in CCA cells. This evidence concerns the gene CDK7 and cholangiocarcinoma.